TGM2 and cancer: Thus in cancer cells an autoregulatory loop exits, in which NF-κB and HIF-1α upregulate the expression of TG2, while TG2 further enhances the NF-κB and HIF-1α-driven transcription including its own transcription resulting in the maintenance of high TG2 levels.